Kochevar Deborah Turner Insider Trades

Insider Trading History

Track insider trading activity for Kochevar Deborah Turner. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $2.19M 94,392 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.7k 4,678 shares
$21.32
$23.18
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $2.08M 89,714 shares
Last Trade
Nov 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 10,314 shares
$23.27
$23.18
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $1.84M 79,400 shares
Last Trade
Nov 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 18,169 shares
$13.21
$23.18
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $1.47M 7,894 shares
Last Trade
May 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427k 1,870 shares
$228.41
$186.60
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $1.42M 61,231 shares
Last Trade
Nov 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 20,374 shares
$11.78
$23.18
Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)
Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) ELAT
Director
Holding Value $1.31M 61,231 shares
Last Trade
Nov 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$434k 20,374 shares
$21.32
$21.32
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $1.37M 7,335 shares
Last Trade
May 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$321k 1,669 shares
$192.36
$186.60
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $947k 40,857 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 18,649 shares
$12.87
$23.18
Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)
Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) ELAT
Director
Holding Value $871k 40,857 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$387k 18,649 shares
$20.74
$21.32
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $1.24M 6,671 shares
Last Trade
May 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 575 shares
$222.31
$186.60
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $515k 22,208 shares
Last Trade
Nov 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 7,307 shares
$28.74
$23.18
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $0 0 shares
Last Trade
Aug 06, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 2,539 shares
$408.41
$186.60
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $1.63M 8,721 shares
Last Trade
Aug 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.43M 3,526 shares
$406.43
$186.60
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $1.8M 9,622 shares
Last Trade
Aug 06, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 2,539 shares
$408.41
$186.60
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $1.32M 7,083 shares
Last Trade
May 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$516k 1,506 shares
$342.55
$186.60
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $345k 14,901 shares
Last Trade
Nov 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 5,885 shares
$30.59
$23.18
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $1.26M 6,728 shares
Last Trade
Aug 07, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$501k 2,319 shares
$216.24
$186.60
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $1.69M 9,047 shares
Last Trade
May 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$539k 3,280 shares
$164.24
$186.60
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $209k 9,016 shares
Last Trade
Nov 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$145k 5,233 shares
$27.71
$23.18
Elanco Animal Health
Elanco Animal Health ELAN
Director
Holding Value $87.7k 3,783 shares
Last Trade
Sep 11, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28k 1,000 shares
$27.95
$23.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up